2. Repository of UKIM
  3. Faculty of Medicine
  4. Faculty of Medicine: Journal Articles

Repository of UKIM


Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/9022
DC FieldValueLanguage
dc.contributor.authorAbizaid, Alexandreen_US
dc.contributor.authorKedev Saskoen_US
dc.contributor.authorKedhi, Elvinen_US
dc.contributor.authorTalwar, Suneelen_US
dc.contributor.authorErglis, Andrejsen_US
dc.contributor.authorHlinomaz, Otaen_US
dc.contributor.authorMasotti, Monicaen_US
dc.contributor.authorFath-Ordoubadi, Farzinen_US
dc.contributor.authorLemos, Pedro Aen_US
dc.contributor.authorMilewski, Krzysztofen_US
dc.contributor.authorBotelho, Robertoen_US
dc.contributor.authorCosta, Ricardoen_US
dc.contributor.authorBangalore, Sripalen_US
dc.date.accessioned2020-09-14T08:45:40Z-
dc.date.available2020-09-14T08:45:40Z-
dc.date.issued2018-12-07-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9022-
dc.description.abstractThe aim of this study was to evaluate the safety and efficacy of the BioMime sirolimus-eluting coronary stent (SES) compared to the XIENCE family of everolimus-eluting coronary stents (EES) in the treatment of patients with de novo native coronary artery lesions.en_US
dc.language.isoenen_US
dc.relation.ispartofEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiologyen_US
dc.titleRandomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trialen_US
dc.typeArticleen_US
dc.identifier.doi10.4244/EIJ-D-18-00762-
dc.identifier.volume14-
dc.identifier.issue11-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

245
checked on Apr 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.